SE441188B - Ny antibiotisk substans, a/16686, framstelld genom odling av ny mikroorganism, actinoplanes sp atcc 33076, forfarande for framstellning derav samt farmaceutisk komposition innehallande den antibiotiska substansen a/1668 - Google Patents

Ny antibiotisk substans, a/16686, framstelld genom odling av ny mikroorganism, actinoplanes sp atcc 33076, forfarande for framstellning derav samt farmaceutisk komposition innehallande den antibiotiska substansen a/1668

Info

Publication number
SE441188B
SE441188B SE8002601A SE8002601A SE441188B SE 441188 B SE441188 B SE 441188B SE 8002601 A SE8002601 A SE 8002601A SE 8002601 A SE8002601 A SE 8002601A SE 441188 B SE441188 B SE 441188B
Authority
SE
Sweden
Prior art keywords
butanol
water
methanol
antibiotic
acid
Prior art date
Application number
SE8002601A
Other languages
English (en)
Swedish (sv)
Other versions
SE8002601L (sv
Inventor
B Cavalleri
H Pagani
G Volpe
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of SE8002601L publication Critical patent/SE8002601L/xx
Publication of SE441188B publication Critical patent/SE441188B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
    • C10G49/00—Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00
    • C10G49/02—Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00 characterised by the catalyst used
    • C10G49/08—Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00 characterised by the catalyst used containing crystalline alumino-silicates, e.g. molecular sieves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J29/00—Catalysts comprising molecular sieves
    • B01J29/04—Catalysts comprising molecular sieves having base-exchange properties, e.g. crystalline zeolites
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/20—Silicates
    • C01B33/26—Aluminium-containing silicates, i.e. silico-aluminates
    • C01B33/28—Base exchange silicates, e.g. zeolites
    • C01B33/2807—Zeolitic silicoaluminates with a tridimensional crystalline structure possessing molecular sieve properties; Isomorphous compounds wherein a part of the aluminium ore of the silicon present may be replaced by other elements such as gallium, germanium, phosphorus; Preparation of zeolitic molecular sieves from molecular sieves of another type or from preformed reacting mixtures
    • C01B33/2884—Zeolitic silicoaluminates with a tridimensional crystalline structure possessing molecular sieve properties; Isomorphous compounds wherein a part of the aluminium ore of the silicon present may be replaced by other elements such as gallium, germanium, phosphorus; Preparation of zeolitic molecular sieves from molecular sieves of another type or from preformed reacting mixtures the aluminium or the silicon in the network being partly replaced
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425—Catalysts; their physical properties
    • C07C1/043—Catalysts; their physical properties characterised by the composition
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425—Catalysts; their physical properties
    • C07C1/043—Catalysts; their physical properties characterised by the composition
    • C07C1/0435—Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425—Catalysts; their physical properties
    • C07C1/043—Catalysts; their physical properties characterised by the composition
    • C07C1/0435—Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof
    • C07C1/044—Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof containing iron
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
    • C10G35/00—Reforming naphtha
    • C10G35/04—Catalytic reforming
    • C10G35/06—Catalytic reforming characterised by the catalyst used
    • C10G35/065—Catalytic reforming characterised by the catalyst used containing crystalline zeolitic molecular sieves, other than aluminosilicates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2529/00—Catalysts comprising molecular sieves
    • C07C2529/04—Catalysts comprising molecular sieves having base-exchange properties, e.g. crystalline zeolites, pillared clays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/827—Actinoplanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Geology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE8002601A 1979-04-07 1980-04-03 Ny antibiotisk substans, a/16686, framstelld genom odling av ny mikroorganism, actinoplanes sp atcc 33076, forfarande for framstellning derav samt farmaceutisk komposition innehallande den antibiotiska substansen a/1668 SE441188B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7912298 1979-04-07

Publications (2)

Publication Number Publication Date
SE8002601L SE8002601L (sv) 1980-12-01
SE441188B true SE441188B (sv) 1985-09-16

Family

ID=10504421

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8002601A SE441188B (sv) 1979-04-07 1980-04-03 Ny antibiotisk substans, a/16686, framstelld genom odling av ny mikroorganism, actinoplanes sp atcc 33076, forfarande for framstellning derav samt farmaceutisk komposition innehallande den antibiotiska substansen a/1668

Country Status (30)

Country Link
US (2) US4303646A (el)
JP (2) JPS5697237A (el)
AR (1) AR222217A1 (el)
AT (1) AT370130B (el)
AU (2) AU533951B2 (el)
BE (1) BE882632A (el)
CA (1) CA1142866A (el)
CH (1) CH655515B (el)
DE (1) DE3013246A1 (el)
DK (1) DK149336C (el)
ES (1) ES490236A0 (el)
FI (1) FI65630C (el)
FR (1) FR2452931A1 (el)
GR (1) GR67279B (el)
HK (1) HK23584A (el)
HU (1) HU181534B (el)
IE (1) IE49327B1 (el)
IL (1) IL59704A (el)
IT (1) IT1212411B (el)
LU (1) LU82327A1 (el)
MX (1) MX5958E (el)
NL (1) NL192989C (el)
NO (1) NO155496C (el)
NZ (1) NZ193357A (el)
PH (1) PH17230A (el)
PT (1) PT71064A (el)
SE (1) SE441188B (el)
SG (1) SG22687G (el)
YU (1) YU41917B (el)
ZA (1) ZA801629B (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE7031T1 (de) 1980-08-16 1984-04-15 Gruppo Lepetit S.P.A. Antibiotikum a/16686 faktor a2, verfahren zu dessen herstellung und die gleichzeitig hergestellten antibiotika a/16686 faktoren a1 und a3.
US4375513A (en) * 1980-12-18 1983-03-01 Eli Lilly And Company Biologically pure culture of Actinoplanes missouriensis
US4859599A (en) * 1984-10-11 1989-08-22 The Dow Chemical Company Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
US4613503A (en) * 1984-10-11 1986-09-23 The Dow Chemical Company Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
GB8624806D0 (en) * 1986-10-16 1986-11-19 Pfizer Ltd Glycopeptide antibiotic
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
GB8729989D0 (en) * 1987-12-23 1988-02-03 Lepetit Spa Novel hydrogenated derivatives of antibiotic a/16686
GB8808658D0 (en) * 1988-04-13 1988-05-18 Lepetit Spa Aglycons of a/16686 antibiotics
AU2001245263A1 (en) * 2000-01-21 2001-07-31 Kosan Biosciences, Inc. Method for cloning polyketide synthase genes
US7257562B2 (en) * 2000-10-13 2007-08-14 Thallion Pharmaceuticals Inc. High throughput method for discovery of gene clusters
JP2004510449A (ja) * 2000-10-13 2004-04-08 エコピア　バイオサイエンス　インク ラモプラニン生合成用遺伝子クラスター
US20030211567A1 (en) * 2001-07-24 2003-11-13 Ecopia Biosciences, Inc. Compositions, methods and systems for discovery of lipopeptides
EP1483286A1 (en) * 2002-03-08 2004-12-08 Vicuron Pharmaceuticals, Inc. A process for the production of ramoplanin-like amide derivatives
WO2003089641A2 (en) * 2002-04-17 2003-10-30 Ecopia Biosciences Inc. Dual condensation/epimerization domain in non-ribosomal peptide synthetase systems
WO2003103699A1 (en) * 2002-06-06 2003-12-18 Vicuron Pharmaceuticals Inc. Use of ramoplanin to treat diseases associated with the use of antibiotics
WO2004017925A2 (en) * 2002-08-23 2004-03-04 Genome Therapeutics Corporation Methods and reagents for preventing bacteremias
US20040127403A1 (en) * 2002-09-06 2004-07-01 Francesco Parenti Methods for treating and preventing Gram-positive bacteremias
WO2004096143A2 (en) * 2003-04-25 2004-11-11 Oscient Pharmaceuticals Corporation Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility
WO2015161074A1 (en) 2014-04-16 2015-10-22 Nanotherapeutics, Inc. Methods of treatment of c. difficile spores with ramoplanin
US20180002741A1 (en) 2016-07-01 2018-01-04 The United States Of America As Represented By The Department Of Veterans Affairs Method of diagnosis and treating gastrointestinal and neurological diseases associated with species of genus clostridium

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790627A (fr) * 1971-10-27 1973-04-27 Lilly Co Eli L'antibiotique a477 et son procede de preparation
GB1458512A (en) * 1973-11-22 1976-12-15 Lepetit Spa Antibiotic substance
US4038383A (en) * 1975-01-17 1977-07-26 Pfizer Inc. Mixture of antibiotics produced by a species of actinoplanes
US4001397A (en) * 1975-08-11 1977-01-04 Pfizer Inc. Antibiotic compound 41,012
US4115552A (en) * 1976-04-19 1978-09-19 Eli Lilly And Company Factor A and B of antibiotic A-4696
US4169887A (en) * 1978-02-21 1979-10-02 Pfizer Inc. Antibiotics produced by species of actinoplanes
JPS54135703A (en) * 1978-04-11 1979-10-22 Dainippon Pharmaceut Co Ltd Antibiotic ab-102 and preparation thereof

Also Published As

Publication number Publication date
JPS62282579A (ja) 1987-12-08
FR2452931A1 (fr) 1980-10-31
JPS6251274B2 (el) 1987-10-29
NL8001982A (nl) 1980-10-09
YU41917B (en) 1988-02-29
CH655515B (el) 1986-04-30
NO155496C (no) 1987-04-08
NO800869L (no) 1980-10-08
JPS5697237A (en) 1981-08-05
FI65630C (fi) 1984-06-11
IL59704A0 (en) 1980-06-30
AU535727B2 (en) 1984-04-05
GR67279B (el) 1981-06-26
DE3013246A1 (de) 1980-10-16
SE8002601L (sv) 1980-12-01
IT1212411B (it) 1989-11-22
IE49327B1 (en) 1985-09-18
HK23584A (en) 1984-03-23
US4303646A (en) 1981-12-01
US4328316A (en) 1982-05-04
IL59704A (en) 1983-11-30
NL192989C (nl) 1998-07-03
IT8021162A0 (it) 1980-04-03
ZA801629B (en) 1981-03-25
AU5903680A (en) 1980-12-11
DK140080A (da) 1980-10-08
HU181534B (en) 1983-10-28
FI800881A (fi) 1980-10-08
NL192989B (nl) 1998-03-02
FI65630B (fi) 1984-02-29
JPS6320514B2 (el) 1988-04-27
MX5958E (es) 1984-09-06
AU5703680A (en) 1980-10-09
DK149336B (da) 1986-05-05
NZ193357A (en) 1982-12-07
BE882632A (fr) 1980-10-03
SG22687G (en) 1989-07-07
IE800697L (en) 1980-10-07
ES8103170A1 (es) 1981-02-16
DK149336C (da) 1986-10-13
ATA187480A (de) 1982-07-15
CA1142866A (en) 1983-03-15
DE3013246C2 (el) 1987-11-19
AR222217A1 (es) 1981-04-30
FR2452931B1 (el) 1983-07-01
YU93580A (en) 1983-06-30
LU82327A1 (fr) 1981-12-02
PT71064A (en) 1980-05-01
AT370130B (de) 1983-03-10
AU533951B2 (en) 1983-12-22
ES490236A0 (es) 1981-02-16
NO155496B (no) 1986-12-29
PH17230A (en) 1984-07-03

Similar Documents

Publication Publication Date Title
SE441188B (sv) Ny antibiotisk substans, a/16686, framstelld genom odling av ny mikroorganism, actinoplanes sp atcc 33076, forfarande for framstellning derav samt farmaceutisk komposition innehallande den antibiotiska substansen a/1668
CA1182447A (en) Derivatives of actaplanin
Coronelli et al. Purpuromycin, a new antibiotic isolated from Actinoplanes ianthinogenes N. sp.
Matson et al. AT2433-A1, AT2433-A2, AT2433-B1, and AT2433-B2 NOVEL ANTITUMOR ANTIBIOTIC COMPOUNDS PRODUCED BY ACTINGMADURA MELLIAURA TAXONOMY, FERMENTATION, ISOLATION AND BIOLOGICAL PROPERTIES
Hayashi et al. WS9326A, A NOVEL TACHYKININ ANTAGONIST ISOLATED FROM Streptomyces violaceusniger No. 9326 I. TAXONOMY, FERMENTATION, ISOLATION, PHYSICO-CHEMICAL PROPERTIES AND BIOLOGICAL ACTIVITIES
CA1339348C (en) Novel glycopeptide antibiotics
EP0010421B1 (en) Mixture of antibiotics designated by a-21978, process for its production, their pharmaceutical compositions and producing microorganism
EP0046201B1 (en) Antibiotic a/16686 factor a2, the process for the preparation thereof, and the co-produced antibiotic a/16686 factors a1 and a3
EP0298640B1 (en) A new antimicrobial agent, fr 109615 and production thereof
EP0182152B1 (en) Antitumor antibiotics (LL-E33288 Complex)
US20110286996A1 (en) Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof
EP0241285A2 (en) Antibiotic A42125 and process for its production
GB2045231A (en) Antibiotic A/16686 and its preparation from actinoplanes
KR830001443B1 (ko) 항생물질 a/16686의 제법
US6586393B2 (en) Antibiotics GE 23077, pharmaceutically acceptable salts and compositions, and use thereof
CA1090728A (en) Antibiotic a-7413 mixture comprising factors a,b,c and d and a process for producing it
CA1086669A (en) Antibiotic substance
NZ205380A (en) Antibiotic/complex and its production
CA1263621A (en) Fr-900848 substance and preparation thereof
US5140101A (en) Antiviral antibiotic BU-4344V
EP0209971A1 (en) Polyether antibiotic and process for its production
CA1077421A (en) Antibiotic sf-1540 from streptomyces
US5256548A (en) Antiviral antibiotic BU-4344V
US4366147A (en) Antibiotic A-7413 and process for preparation thereof
EP1213298A1 (en) Antibiotics GE 23077, pharmaceutically acceptable salts and compositions, and use thereof

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8002601-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8002601-6

Format of ref document f/p: F